Director, G2P Research Program (genomes2people.org), Division of Genetics, Brigham and Women's Hospital, Broad Institute, Harvard Medical SchoolBiography
Robert C. Green, MD, MPH is a medical geneticist and physician-scientist who directs the G2P Research Program (genomes2people.org) in translational genomics and health outcomes in the Division of Genetics at Brigham and Women's Hospital, the Broad Institute and Harvard Medical School. Dr. Green is internationally recognized for designing and conducting empirical research that is accelerating the responsible implementation of genomic medicine. He led the first experimental trials disclosing common complex disease risk (the REVEAL Study) and one of the first prospective studies of direct-to-consumer genetic testing services (the PGen Study). He currently leads and co-leads the first randomized trials to explore the implementation of medical sequencing in adults (the MedSeq Project) and newborns (the BabySeq Project), respectively.